Biotage Achieves ISO 14001:2004 Certification
News Jun 14, 2016
Biotage is pleased to announce that they have achieved ISO 14001:2004 certification. This comes after years of dedicated work and close collaboration between employees, consultants and managerial staff.
In addition to establishing a series of quality standards regarding business practices and the environment, ISO 14001:2004 certification also comes with various other benefits to the titleholder, including: reduction of costs through efficient use of materials and management of legal compliance by prioritizing environmental risks.
“We at Biotage are incredibly honored to receive ISO 14001 certification of our environmental management systems that have been developed over the years. This certification is much more than just legal compliance; for us, it is a driver by which Biotage can effectively manage responsible business practices that seek to limit negative environmental impact through control of emissions and other potentially harmful actions” said Chris Williams, UK Managing Director, Biotage.
ISO 14001:2004 helps businesses like Biotage manage challenges, systems and risks concerning environmental performance. The certification serves as assurance to management, employees and external partners that the environmental impact of operations is being measured, monitored and continually improved.
Biotage’s official certification of its environmental management system was confirmed on 5th May 2016 by BSI, the reputable certification body that provides compliance, risk, and technical support.
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug DiscoveryNews
Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.READ MORE
Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity TreatmentNews
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.READ MORE
Reversing an Unstoppable Cancer Cascade with ProteomicsNews
Mutations in genes that produce RAS proteins turn a normally benign process, essential for cellular growth, into a cancer stimulant that is currently undruggable. Now, cutting-edge protein analysis may help treat cancers caused by these mutations.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018